Browse by author
Lookup NU author(s): Dr Aneta Mikulasova, Dan Kent, Dr Marco Trevisan-HerrazORCiD, Nefeli Karataraki, Kent Fung, Dr Daniel Rico RodriguezORCiD, Dr Lisa Russell
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Author(s): Mikulasova A, Kent D, Trevisan-Herraz M, Karataraki N, Fung KTM, Ashby C, Cieslak A, Yaccoby S, van Rhee F, Zangari M, Thanendrarajan S, Schinke C, Morgan GJ, Asnafi V, Spicuglia S, Brackley CA, Corcoran AE, Hambleton S, Walker BA, Rico D, Russell LJ
Publication type: Article
Publication status: Published
Journal: Genome Research
Year: 2022
Volume: 32
Pages: 1343-1354
Print publication date: 01/07/2022
Online publication date: 21/12/2021
Acceptance date: 15/12/2021
Date deposited: 22/07/2022
ISSN (print): 1088-9051
ISSN (electronic): 1549-5469
Publisher: Cold Spring Harbor Laboratory Press
URL: https://doi.org/10.1101/gr.276042.121
DOI: 10.1101/gr.276042.121
Data Access Statement: The DNA sequencing data for the U266, KMS11, and MM1S myeloma cell lines generated in this study have been submitted to the NCBI BioProject database (https://www.ncbi.nlm.nih.gov/bioproject/) under accession number PRJNA635269. All raw and processed ChIP-seq data for the KMS11 and MM1S myeloma cell lines, as well as the PEER T-ALL cell line, have been submitted to the NCBI Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE151556. All high-throughput sequencing data for the MM PDXs have been submitted to the European Genome-phenome Archive (https://ega-archive.org/) under accession number EGAS00001005684.
PubMed id: 34933939
Altmetrics provided by Altmetric